Real-World Data Study to Understand Effectiveness of Treatments in Peyronie's Disease (CURVE-PD)

Endo Pharmaceuticals

Status: Terminated

Conditions: Peyronie's Disease

Study type: Observational

Funder types: Industry

Identifiers

NCT05873595

EP02REG

Details and patient eligibility

About

This is an observational study, meaning participants will not receive any investigational treatment as part of this study.

Researchers will collect real-world data (RWD) to gain a more in-depth knowledge of the treatment of Peyronie's Disease (PD) to evaluate the management of PD.

Full description

Each participant of the study will have their data collected from the date of confirmed diagnosis of PD to the date of enrollment in the registry, post consent. Data will be collected from the participant's clinical records as well as from the participant directly. Data will be collected through Pulse Infoframe's technology platform.

Enrollment: 29 patients

Sex: Male

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Key Inclusion Criteria:

• Any adult with a confirmed clinical diagnosis of PD.
• Age 18 years (or age of majority in their jurisdiction) or older at time of enrollment.
• Willing to participate in the registry (including completion of ePROs) and complete the informed consent form.
• Having received PD treatment within 2 weeks before enrollment, at enrollment or any time after the date of enrollment. After a confirmed diagnosis of PD, not having received PD treatment.
• Able to participate in English based registry.

Key Exclusion criteria:

• Not having a clinical diagnosis of PD.
• Age less than 18 years.
• Do not provide informed consent.